Beverly Oncology & Imaging is categorized under Oncologists in Alhambra, CA .
Beverly Oncology & Imaging was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Belen Delgado, Office Manager at the company’s single location by writing to 80 South Palm Avenue, Alhambra, California CA 91801 or by phoning (626) 571-6729. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Beverly Oncology & Imaging |
| Contact Person: | Belen Delgado, Office Manager |
| Address: | 80 South Palm Avenue, Alhambra, California 91801 |
| Phone Number: | (626) 571-6729 |
| Website Address: | beverlyoncology.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Beverly Oncology & Imaging was started in 0 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Belen Delgado, Office Manager for inquiries that concern Beverly Oncology & Imaging by calling the company number (626) 571-6729, as your correspondence is most welcome. Additionally, the physical location of the single location of Beverly Oncology & Imaging can be found at the coordinates 34.09011,-118.14631 as well as the street address 80 South Palm Avenue in Alhambra, California 91801.
For its online presence, you may visit Beverly Oncology & Imaging’s website at beverlyoncology.com and engage with its social media outlets through on Twitter and on Facebook.